October 27, 2020 12:40 pm US Officials Cut Short COVID-19 Antibody Trial U.S. regulators have ended one of Eli Lilly’s COVID-19 antibody trials early after data suggested the drug was “unlikely to help” coronavirus patients recover. US & World Videos 3:02 JoJo Siwa got punched during 21st birthday celebration 1:16 Own an iPhone? You could be eligible for a payout as part of a $35 million settlement 1:54 WATCH: Animals snack on cicadas at Chicago zoo 4:59 ‘Collective failure': Families of Uvalde shooting victims file lawsuit over police response and alleged ‘cover up' 1:12 Norway, Ireland and Spain announce they are recognizing a Palestinian state